COP — CompuGroup Medical SE & Co KgaA Income Statement
0.000.00%
- €1.40bn
- €2.11bn
- €1.21bn
Annual income statement for CompuGroup Medical SE & Co KgaA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1,025 | 1,130 | 1,188 | 1,154 | 1,213 |
| Cost of Revenue | |||||
| Gross Profit | 871 | 958 | 1,005 | 967 | 1,012 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 923 | 1,031 | 1,074 | 1,047 | 1,124 |
| Operating Profit | 103 | 98.8 | 113 | 107 | 89 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 97.9 | 107 | 72.7 | 61.9 | 57.6 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 69 | 74.1 | 46.9 | 34.8 | 28.7 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 69 | 73.4 | 45.9 | 34.6 | 28.2 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 69 | 73.4 | 45.9 | 34.6 | 28.2 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 1.23 | 1.67 | 1.39 | 1.48 | 0.952 |
| Dividends per Share |